Artificial Intelligence, Machine Learning, and Natural Language Processing technologies like GPT-3 are revolutionizing the heart disease industry by improving patient outcomes and care. Companies like Heart Flow and Owkin are utilizing these technologies to analyze medical images and genomic data, leading to more accurate diagnosis and personalized treatment for heart disease patients.
Read more
Heart Health Technologies has developed a new touchless blood pressure screening technology that utilizes AI and machine learning to measure blood pressure without a cuff, potentially revolutionizing the way heart disease is monitored and managed. This technology aims to provide more convenient and accurate blood pressure readings for consumers, leading to better heart disease prevention and management, ultimately benefiting companies like Apple, Fitbit, and Samsung who are looking to expand their presence in the heart health industry.
Read more
Artificial intelligence is being used in healthcare applications to improve the diagnosis and treatment of heart disease. Companies like Caption Health are using machine learning to provide real-time guidance for medical professionals during cardiac ultrasounds, while HeartFlow is using deep learning to create 3D models of patients' coronary arteries to help diagnose heart disease more accurately.
Read more
Artificial intelligence and machine learning technologies like LLMs and GPT are being used to analyze medical images for heart disease detection, which can also lead to the discovery of other health conditions. Companies like Caption Health and Zebra Medical Vision are at the forefront of using AI to improve diagnosis and treatment in the heart disease industry, benefiting consumers by providing more accurate and efficient healthcare solutions.
Read more
Philips and Mayo Clinic have collaborated to use Artificial Intelligence to enhance cardiac MRI technology, reducing scan times and improving image quality for better diagnosis of heart conditions. This innovation in AI technology is transforming the way heart disease is diagnosed and treated, benefiting both healthcare providers and patients in the cardiovascular industry.
Read more
Cleerly debuted at RSNA 2024 showcasing AI-enabled innovations in cardiovascular imaging, specifically focusing on utilizing AI and Machine Learning to improve the accuracy of diagnosing heart disease. Cleerly's AI platform combines advanced imaging techniques with deep learning algorithms to provide precision diagnostics for heart disease, revolutionizing the industry and benefiting both heart disease companies and product consumers.
Read more
Deep learning technology, specifically a convolutional neural network (CNN) called the MyoNet, has shown promise in improving the accuracy and efficiency of assessing myocardial function on coronary CT angiography (CCTA) scans. This innovative approach developed by researchers from Munich, Germany aims to enhance the diagnostic capabilities of heart disease imaging, potentially benefiting heart disease patients and healthcare providers such as Siemens Healthineers and GE Healthcare.
Read moreArtificial intelligence is being used to improve the effectiveness of heart failure treatments, with companies like HeartFlow and HeartBeam developing AI-powered solutions for diagnosing and treating heart disease. Machine learning algorithms are being utilized to analyze medical imaging data and provide personalized treatment recommendations for patients, leading to more accurate diagnoses and improved outcomes in the heart disease industry.
Read moreArtificial Intelligence tools such as LLMs and GPT-3 can help identify patients with diabetes at highest risk for cardiomyopathy, a type of heart disease. Companies like Cardiogram have developed AI algorithms that analyze heart rate data to predict the likelihood of developing various heart conditions, providing valuable insights for healthcare providers and consumers.
Read moreMedera has published a study demonstrating the use of machine learning to improve drug screening with human mini-heart technology, showcasing the potential for AI to revolutionize the heart disease industry. By utilizing advanced AI techniques such as deep learning and neural networks, companies like Medera can optimize drug development processes and improve outcomes for heart disease patients through innovative products and personalized treatments.
Read more
NEC X has invested in Gpx to advance AI-driven chronic disease monitoring, specifically focusing on heart disease. Gpx's technology utilizes Natural Language Processing (NLP) and Machine Learning to provide personalized insights for heart disease patients, improving outcomes and reducing healthcare costs.
Read more
Eko Health has received a Category III CPT code for their Sensora AI platform, which uses Artificial Intelligence to detect heart disease. This platform utilizes Machine Learning and Neural Networks to analyze heart sounds and provide accurate diagnoses, offering a significant advancement in the heart disease industry for both companies and consumers.
Read moreAnumana will showcase AI-driven cardiovascular solutions at AHA and NAPCRG 2024, using advanced technologies such as Machine Learning and Neural Networks to improve heart disease detection and treatment for consumers. This will have a significant impact on the heart disease industry, benefiting companies like Anumana and consumers seeking effective products and services in managing heart conditions.
Read more
Cardiosense presented interim clinical study data for their machine learning algorithm designed to aid in heart failure management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium. The algorithm, utilizing artificial intelligence and deep learning, aims to improve patient outcomes and reduce hospital readmissions by providing real-time monitoring and analysis of heart health data.
Read moreAn AI algorithm called DeepHEART has been developed to accurately diagnose heart disease using electrocardiogram (ECG) data, with a success rate of 90%. This technology has the potential to revolutionize the heart disease industry and benefit companies like Philips Healthcare or Siemens Healthineers, ultimately improving outcomes for heart disease patients such as those using medical devices like Abbott's cardiac monitoring systems.
Read more
The article discusses how a study called CONFIRM2 demonstrated the effectiveness of using Artificial Intelligence in quantifying coronary artery disease events by analyzing plaque features. By utilizing Machine Learning algorithms, researchers were able to predict cardiovascular events in patients more accurately, leading to potential advancements in the diagnosis and treatment of heart disease. An example mentioned in the article is the use of Deep Learning techniques to analyze images from coronary computed tomography angiography (CCTA) scans, which could provide valuable insights for companies like HeartFlow and HeartFlow Analysis.
Read moreArtificial Intelligence models such as GTEX and CVext can effectively stratify the risk of coronary artery disease in patients based on PET/CT imaging data, offering a more accurate and efficient diagnostic approach in the healthcare industry. Companies like HeartFlow are developing AI-powered solutions like the HeartFlow Analysis to aid in the assessment and diagnosis of heart disease, ultimately benefiting consumers by providing personalized and timely care.
Read more
Artificial intelligence and machine learning technologies are revolutionizing the way first responders in the Heart Disease industry operate, with companies like HeartFlow utilizing deep learning algorithms to improve the accuracy of diagnosing and treating heart disease. These technologies are enhancing the efficiency and effectiveness of emergency response teams, allowing for quicker intervention and potentially saving more lives in a time-critical industry.
Read more
Texas-based tech companies like PCCI and HeartTest are using artificial intelligence and machine learning to revolutionize the heart disease industry by developing innovative products for early detection and personalized care. Through advancements in natural language processing, computer vision, and neural networks, these companies are improving outcomes for heart disease patients and transforming the way healthcare providers diagnose and treat cardiovascular conditions.
Read more
Artificial intelligence and machine learning technologies such as Generative AI, LLMs, and GPT are being used in the healthcare industry to improve remote patient monitoring for conditions like heart disease. Companies like Biofourmis and Current Health are leveraging these technologies to provide more personalized and efficient care to patients through advanced analytics and predictive algorithms.
Read more
Boston is at the forefront of personalized medicine, with companies like VeriSIM Life using AI and machine learning to create virtual patients and simulate drug responses. Other companies like HeartFlow are using deep learning and computer vision to improve the diagnosis and treatment of heart disease by analyzing detailed blood flow data and identifying blockages in arteries. This revolutionary approach is transforming the traditional healthcare industry and providing more accurate and personalized treatment options for patients with heart disease.
Read moreArtificial Intelligence and Big Data analytics are revolutionizing the heart disease industry, with companies like Cardiogram using machine learning algorithms to predict heart conditions in patients through wearable devices. This technology is enabling better diagnosis, treatment, and prevention of heart disease, ultimately improving outcomes for consumers and reducing healthcare costs.
Read moreHeartFlow, a leader in AI-powered heart disease diagnosis, recently received a decision from CMS approving reimbursement for coronary computed tomography angiography (CCTA) with their HeartFlow Analysis software, providing improved access for patients. This decision showcases the growing influence of AI and machine learning technologies in the healthcare industry, specifically within the cardiovascular sector, as companies like HeartFlow are utilizing these advancements to enhance diagnostic accuracy and patient outcomes.
Read more
Vietnam has approved a Korean predictive AI technology for early detection of sepsis in hospitals, showing the potential of AI in improving outcomes for patients with infections like sepsis. This AI technology, developed by Vuno Inc., uses deep learning algorithms to analyze medical data and predict when a patient is at risk for sepsis, demonstrating the growing impact of AI and machine learning in the healthcare industry.
Read more
An Australian university has teamed up with Apollo Hospitals to improve digital health research with a special focus on heart diseases, using artificial intelligence, machine learning, and natural language processing to analyze data. This partnership aims to develop personalized treatment plans for cardiac patients using innovative predictive tools like Myron AI, enhancing outcomes for individuals with heart disease.
Read moreWould you like us to add an industry? Let us know
Would you like us to add a health topic? Let us know
Would you like us to add a profession? Let us know
Would you like us to add a location? Let us know
Create AI solutions up to 17x faster with our low-code development platform
Supercharge your workplace with a secure, private, local AI management application tailored to deliver enhanced business solutions.
Synchronize your workforce with an AI-driven management system that optimizes task delegation, and communication to empower frontline teams and boost productivity.
